“Macrocycles by the Trillions” Joanne Kotz. 26 January 2012
Macrocycles: Going where no drugs have gone before Mari Serabrov. 2011 November 28
Ensemble Therapeutics Moves Ahead With Mid-Sized Drugs in a Super-Sized Library Luke Timmerman. 2011 July 19
Delivery Of First Macrocyle To Bristol-Myers Squibb Enables Ensemble Therapeutics To Look Ahead Joseph Haas. 2011 April 12
Ensemble hits Macrocycle Milestone Carmen Drahl. 2011 April 12
Making mid-sized macrocyclic molecules, en masse Deborah Erickson. 2011 March: Vol. 16 No. 3
Company Profile: Chemical Ensemble Sarah Houlton. 2011 March
Ensemble Discovery's CEO, Dr. Mike Taylor, discussing Pfizer alliance on NECN. January 6, 2010
Constraining molecules in macrocyclic rings could help address challenges in drug discovery Andrew Good & Jodi Muckelbauer/BMS. 2009 Sep 7;Volume 87, Number 36 pp. 54-57
Breaking the Rule (of Five) Kevin Davies. 2008 Apr 1
1/5/2012 - Ensemble Therapeutics Advances Macrocycle IL-17 Antagonist Program: Reports First Known Small Molecule Inhibitors of Important Autoimmune Target
1/5/2012 - Ensemble Therapeutics Extends Macrocycle Drug Discovery Alliance with Bristol-Myer Squibb
7/6/2011 - Ensemble Therapeutics Receives Two Notices of Allowance for Fundamental Patents to DNA-Programmed Chemistry Process for Novel Macrocycle Therapeutics
4/12/2011 - Ensemble Therapeutics Achieves Milestone in Bristol-Myers Squibb Collaboration
11/2/2010 - Ensemble Awarded Three Therapeutic Discovery Project Grants Totaling $744,000
9/15/2010 - Ensemble Therapeutics Appoints Ted Hibben as Senior Vice President, Corporate Development
8/23/2010 - Ensemble Therapeutics Presents Data at American Chemical Society National Meeting
6/22/2010 - Ensemble Evolves Name to Ensemble Therapeutics Corporation and Also Announces New Strategic Investor: Kisco Ltd.
1/6/2010 - Ensemble Discovery Initiates Collaboration with Pfizer to Develop Novel Drugs Against Protein-Protein Interaction Targets
4/15/2009 - Ensemble Discovery Initiates Collaboration with Bristol-Myers Squibb to Develop Drugs in Novel Therapeutic Class
11/13/2008 - Ensemble Discovery and Roche Initiate Product Development Program to Advance New Diagnostic Technology to Optimize Cancer Therapy
